Investing.com – Denmark equities were lower at the close on Monday, as losses in the Oil & Gas, Healthcare and Real Estate sectors propelled shares lower.
At the close in Copenhagen, the OMX Copenhagen 20 fell 0.74%.
The biggest gainers of the session on the OMX Copenhagen 20 were Genmab (CSE:GMAB), which rose 0.60% or 11.00 points to trade at 1,833.50 at the close. Oersted AS (CSE:ORSTED) added 0.52% or 2.00 points to end at 384.30 and Novozymes A/S B (CSE:NSISb) was up 0.40% or 1.80 points to 450.70 in late trade.
Biggest losers included GN Store Nord (CSE:GN), which lost 3.58% or 5.90 points to trade at 158.80 in late trade. Zealand Pharma A/S (CSE:ZELA) declined 2.81% or 24.50 points to end at 848.00 and AP Moeller - Maersk A/S B (CSE:MAERSKb) shed 1.89% or 200.00 points to 10,370.00.
Declining stocks outnumbered rising ones by 70 to 56 and 25 ended unchanged on the Copenhagen Stock Exchange.
In commodities trading, Crude oil for October delivery was up 3.17% or 2.37 to $77.20 a barrel. Meanwhile, Brent oil for delivery in November rose 2.55% or 1.99 to hit $80.14 a barrel, while the December Gold Futures contract rose 0.04% or 0.90 to trade at $2,547.20 a troy ounce.
USD/DKK was up 0.24% to 6.68, while EUR/DKK unchanged 0.01% to 7.46.
The US Dollar Index Futures was up 0.13% at 100.74.